| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 04/29/2004 | WO2003025128A9 Quinone reductase 2 and aldehyde dehydrogenase as therapeutic targets |
| 04/29/2004 | WO2003020949A3 Targeted nucleic acid constructs and uses related thereto |
| 04/29/2004 | WO2003013537A9 Irinotecan for treatment of cancer |
| 04/29/2004 | WO2003013536A9 Methods for treatment of cancer using irinotecan based on ugt1a1 |
| 04/29/2004 | WO2003013535A9 Use of irinotecan for improved treatment of cancer based on mdr1 |
| 04/29/2004 | WO2003013534A9 Methods for the treatment of cancer with irinotecan based on cyp3a5 |
| 04/29/2004 | WO2003013533A9 Methods for improved treatment of cancer with irinotecan based on mrp1 |
| 04/29/2004 | WO2003010196A3 Variants and exons of the glyt1 transporter |
| 04/29/2004 | WO2003003006A3 New potent, selective and non toxic c-kit inhibitors |
| 04/29/2004 | WO2003003004A3 Method for identifying compounds the specifically deplete mast cells |
| 04/29/2004 | WO2002103051A3 Nucleic acid triplex and quadruplex formation |
| 04/29/2004 | WO2002101004A3 Low-temperature cycle extension of dna with high priming specificity |
| 04/29/2004 | WO2002072630A3 Nucleic acid-associated proteins |
| 04/29/2004 | WO2002070748A3 Response of dendritic cells to a diverse set of pathogens |
| 04/29/2004 | WO2002070669A3 Secreted proteins |
| 04/29/2004 | WO2002059347A3 Aberrantly methylated genes as markers of breast malignancy |
| 04/29/2004 | WO2002046372A9 Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites |
| 04/29/2004 | WO2002038796A9 Methods for determining protease cleavage site motifs |
| 04/29/2004 | WO1991000348A3 Modified vp1/p2a regions of the rhinoviral system |
| 04/29/2004 | US20040083496 Genetic engineered polypeptides; incubation, amplification |
| 04/29/2004 | US20040082773 Modified PAR receptors, their preparation and their uses for selecting compounds which modulate PAR activity |
| 04/29/2004 | US20040082761 Cell adhesion proteins |
| 04/29/2004 | US20040082532 Antifungal therapeutic targets |
| 04/29/2004 | US20040082510 Pyk2 phosphorylation by her3 induces tumor invasion |
| 04/29/2004 | US20040082508 For diagnosis/treatment/prevention of cell proliferative/ autoimmune/inflammatory/cardiovascular/neurological diseases |
| 04/29/2004 | US20040082499 Perturbed membrane-binding compounds |
| 04/29/2004 | US20040082080 Activating sample with radiation; complexing target and detector; measurement fluorescence |
| 04/29/2004 | US20040082079 Solid support; detector; providing ligand library ; contacting target; determination, calibrating of binding |
| 04/29/2004 | US20040082064 Stimulanting immunology response; calibrating success of organ, tissue transplant; polymerase chain reaction analysis; administering immunosuppressants |
| 04/29/2004 | US20040082052 Crystal structure |
| 04/29/2004 | US20040082045 Air aperture in sample supplying passageway; electrolytic cells |
| 04/29/2004 | US20040082028 Genetic engineering; three-dimensional construction; heat resistance; used for converting starch to sugar |
| 04/29/2004 | US20040082027 Conjugate of a tissue non-specific alkaline phosphatase and dextran, process for its production and use thereof |
| 04/29/2004 | US20040082017 Protein for drug screening; purification of lysosomes; fusion protein; nucleotide sequence coding polypeptide; quantitative analysis |
| 04/29/2004 | US20040082014 Method and test system for identifying substances which protect nerve cells |
| 04/29/2004 | US20040082013 Methods for screening for substances which inhibit fp prostanoid receptor interaction with a compound having pgf2alpha activity and methods of treating cancer |
| 04/29/2004 | US20040082005 Localization of human cytomegalovirus nucleic acids and proteins in human cancer cells |
| 04/29/2004 | US20040082002 Genetic engineering; screening antagonist; medical diagnosis using antibodies |
| 04/29/2004 | US20040082001 Method and compositions for ordering restriction fragments |
| 04/29/2004 | US20040082000 Identification of genetic components of drug response |
| 04/29/2004 | US20040081998 Novel carboxylesterase nucleic acid molecules, proteins and uses thereof |
| 04/29/2004 | US20040081996 Methods and products related to genotyping and DNA analysis |
| 04/29/2004 | US20040081995 Dna polymerase; genetic engineering |
| 04/29/2004 | US20040081994 Measuring efficiency of exercise; measuring isotropic patterns; sensitivity to cardiovascular disorders |
| 04/29/2004 | US20040081993 Quantification of gene expression |
| 04/29/2004 | US20040081991 Hybrid labeling oligonucleotides; separation of strands; diagnosis of genetic disorders |
| 04/29/2004 | US20040081990 Method for the identification of essential genes and therapeutic targets |
| 04/29/2004 | US20040081989 Infantile neurodegradation disorders; behaviot disorders; anticonvulsants; brain disorders |
| 04/29/2004 | US20040081987 Methods and arrays for detecting biomolecules |
| 04/29/2004 | US20040081984 Ocular tear growth factor-like protein |
| 04/29/2004 | US20040081982 Neocentromere-based mini-chromosomes or artificial chromosomes |
| 04/29/2004 | US20040081981 Method of detecting risk factor for onset of diabetes |
| 04/29/2004 | US20040081980 Polynucleotides; genetic engineering; diagnosis, therapy, prevent disease; detect binding to antibody |
| 04/29/2004 | US20040081978 Random-primed reverse transcriptase-in vitro transcription method for rna amplification |
| 04/29/2004 | US20040081976 Genomic screen for epigenetically silenced tumor suppressor genes |
| 04/29/2004 | US20040081975 Method for the characterization and/or identification of genomes |
| 04/29/2004 | US20040081974 Method and equipment to monitor nucleic acid hybridization on a dna chip using four-dimensional parameters |
| 04/29/2004 | US20040081971 Gastrointestinal disorders; cardiovascular disorders; autoimmune diseases; cell proliferation; antiinflammatory agents |
| 04/29/2004 | US20040081968 Method and mixture for curing autoimmune disease |
| 04/29/2004 | US20040081967 Detector binding to substrate surface; protein layout binding pattern |
| 04/29/2004 | US20040081966 Chemical array linking layers |
| 04/29/2004 | US20040081965 Mutants; genetic engineering; amplification |
| 04/29/2004 | US20040081964 Gene and sequence variation associated with sensing carbohydrate compounds and other sweeteners |
| 04/29/2004 | US20040081962 Nucleic acids amplification |
| 04/29/2004 | US20040081961 Genetic engineering; therapy, diagnosis of disease; gastrointestinal, cardiovascular diseases; autoimmune disease; antiinflammatory agents; central nervous system disorders; antitumor, anticancer agents |
| 04/29/2004 | US20040081959 Using oligonucleotide detectors; hybridization analyzing |
| 04/29/2004 | US20040081958 Identification and use of molecular markers indicating cellular reprogramming |
| 04/29/2004 | US20040081957 Complexing; measurement agglutination, calibration of complex; Aids therapy |
| 04/29/2004 | US20040081658 Epitopes involved in the immune response to human papillomavirus; induction and/or enhancement of a T cell response directed towards an antigen, using peptides comprising specific epitopes for said antigen |
| 04/29/2004 | US20040081652 Administering an isolated molecule comprising an antibody variable region which specifically binds to a neuronal marker protein whereby neuronal cell death in the mammal is inhibited or prevented |
| 04/29/2004 | US20040081641 Orally administering digestive enzyme; measurement, calibration |
| 04/29/2004 | US20040080750 Fluorescence correlation spectroscopy instrument and method of using the same |
| 04/29/2004 | US20040079893 Novel optical architectures for microvolume laser- scanning cytometers |
| 04/29/2004 | US20040079653 Biosensor having improved hematocrit and oxygen biases |
| 04/29/2004 | DE10294485T5 Mit Mnk-Kinase homologe Proteine, die in die Regulation der Energiehomöostase und den Organellenmetabolismus involviert sind Mnk homologous proteins with kinase, that are involved in the regulation of energy homeostasis and the metabolism organelle |
| 04/29/2004 | DE10245779A1 Predicting responsiveness of a subject with breast cell proliferative disorder, useful for treating or differentiating breast cell proliferative disorders comprises analyzing methylation pattern of a genomic DNA from the subject |
| 04/29/2004 | CA2836656A1 Disease detection by digital protein truncation assays |
| 04/29/2004 | CA2503307A1 Soluble rna polymerase protein and methods for the use thereof |
| 04/29/2004 | CA2502723A1 Nucleic acid sequences associated with hiv resistance |
| 04/29/2004 | CA2502559A1 Method and reagent for measuring cholesterol in high density lipoproteins |
| 04/29/2004 | CA2502541A1 Asparaginyl hydroxylases and modulators thereof |
| 04/29/2004 | CA2502454A1 Association of the h2 haplotype of the p2y12 receptor with an increased risk for thrombosis and peripheral arterial disease |
| 04/29/2004 | CA2502359A1 Susceptibility gene for myocardial infarction |
| 04/29/2004 | CA2502357A1 Susceptibility gene for myocardial infarction; methods of treatment |
| 04/29/2004 | CA2502352A1 Use of 4-galactosyl-xylose in humans for the in vivo evaluation o f intestinal lactase as a non-invasive diagnostic test of the deficiency of said enzyme |
| 04/29/2004 | CA2502277A1 Analyte sensors and methods for making them |
| 04/29/2004 | CA2502250A1 Methods using gene trapped stem cells for marking pathways of stem cell differentiation and making and isolating differentiated cells |
| 04/29/2004 | CA2501946A1 Compositions and methods for detecting west nile virus |
| 04/29/2004 | CA2501648A1 Assays to detect or quantify bacterial or viral pathogens and contaminants |
| 04/29/2004 | CA2501095A1 Methods to predict edema as a side effect of drug treatment |
| 04/29/2004 | CA2500255A1 Method and nucleic acids for the treatment of breast cell proliferative disorders |
| 04/29/2004 | CA2486105A1 Differential patterns of gene expression that predict for docetaxel chemosensitivity and chemoresistance |
| 04/29/2004 | CA2468273A1 Disease detection by digital protein truncation assays |
| 04/29/2004 | CA2447172A1 Method, assay, and kit for quantifying hiv protease inhibitors |
| 04/28/2004 | EP1413887A1 Inhibitors of Src kinase for use in Alzheimer's disease |
| 04/28/2004 | EP1413885A2 Use and screening method for an aberrant gene product-operating substance |
| 04/28/2004 | EP1413883A1 Method of reducing analysis time of endpoint-type reaction profiles |
| 04/28/2004 | EP1413630A1 Analyssis of biological targets using a biochip comprising a fluorescent marker |
| 04/28/2004 | EP1413629A1 Method of evaluating biocompatibility |
| 04/28/2004 | EP1413628A1 Method of determining dna base sequence |